BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16608049)

  • 21. Current views of diabetic peripheral neuropathic pain comorbid depression - a review.
    Wei KS; Gu MZ; Zhu JW; Hu HC; Yin LP
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10663-10670. PubMed ID: 33155224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic neuropathy. Helping patients cope with their pain.
    Belgrade MJ; Lev BI
    Postgrad Med; 1991 Oct; 90(5):263-70. PubMed ID: 1681527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duloxetine in the management of diabetic peripheral neuropathic pain.
    Ormseth MJ; Scholz BA; Boomershine CS
    Patient Prefer Adherence; 2011; 5():343-56. PubMed ID: 21845034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical approach to patients with neuropathic pain.
    Stillman M
    Cleve Clin J Med; 2006 Aug; 73(8):726-8, 729-30, 733-6 passim. PubMed ID: 16913197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological treatment of neuropathic pain].
    Ollat H
    Rev Neurol (Paris); 1992; 148(8-9):521-31. PubMed ID: 1337388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the treatment and management of diabetic peripheral neuropathy.
    Donnan J; Ledger S
    CANNT J; 2006; 16(4):32-6; quiz 37-8. PubMed ID: 17252899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice.
    Ziegler D; Schneider E; Boess FG; Berggren L; Birklein F
    J Diabetes Complications; 2014; 28(5):698-704. PubMed ID: 24862108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of illness in painful diabetic peripheral neuropathy.
    Giannopoulos S; Pelidou SH; Kyritsis AP; Kosmidou M
    J Pain; 2007 Jun; 8(6):530. PubMed ID: 17481958
    [No Abstract]   [Full Text] [Related]  

  • 30. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management.
    Tesfaye S; Vileikyte L; Rayman G; Sindrup SH; Perkins BA; Baconja M; Vinik AI; Boulton AJ;
    Diabetes Metab Res Rev; 2011 Oct; 27(7):629-38. PubMed ID: 21695762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).
    Attal N; Mazaltarine G; Perrouin-Verbe B; Albert T;
    Ann Phys Rehabil Med; 2009 Mar; 52(2):124-41. PubMed ID: 19909703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathic pain in cancer.
    Fallon MT
    Br J Anaesth; 2013 Jul; 111(1):105-11. PubMed ID: 23794652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
    Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
    Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newer agents for the treatment of painful diabetic peripheral neuropathy.
    Freeman R
    Curr Diab Rep; 2005 Dec; 5(6):409-16. PubMed ID: 16316590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EFNS guidelines on pharmacological treatment of neuropathic pain.
    Attal N; Cruccu G; Haanpää M; Hansson P; Jensen TS; Nurmikko T; Sampaio C; Sindrup S; Wiffen P;
    Eur J Neurol; 2006 Nov; 13(11):1153-69. PubMed ID: 17038030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy.
    Beyreuther B; Callizot N; Stöhr T
    Eur J Pharmacol; 2006 Jun; 539(1-2):64-70. PubMed ID: 16682022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.
    Sun P; Zhao Y; Zhao Z; Bernauer M; Watson P
    Pain Pract; 2012 Nov; 12(8):641-8. PubMed ID: 22335435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological strategies in relieving neuropathic pain.
    McCleane G
    Expert Opin Pharmacother; 2004 Jun; 5(6):1299-312. PubMed ID: 15163275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall JA; Risser RC; Gonzales JS
    Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacologic therapy in peripheral diabetic polyneuropathy].
    Mihai B; Lăcătuşu C; Graur M; Cijevschi-Prelipcean C; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):332-41. PubMed ID: 20700963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.